Chronic Kidney Disease (CKD) is estimated to affect around 10% of the global population, yet up to one-third of cases remain undiagnosed. Since genetic testing is increasingly
We’re proud to share that 4bases presented a scientific poster introducing InnoGraft — our innovative, minimally invasive solution for monitoring graft rejection in organ transplant patients. Congrats and thanks
CHEK2 is a tumour-suppressing gene which encodes for the CHK2 protein, a serine/threonine kinase which plays a major role in several cell signalling pathways, such as
Breast cancer (BC) is the most frequent type of cancer in women, with approximately 2.2 million new cases diagnosed each year, making it the fourth
The need for genetic diagnosis of hemato-oncology diseases is steadily increasing, driven by the advent of precision medicine. This month’s recommended reading: “Hereditary cancer syndrome-associated
Powered by Lifency SA © 2025